Allspring Global Investments
RYTM icon

Allspring Global Investments’s Rhythm Pharmaceuticals RYTM Stock Holding History

Allspring Global Investments’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-26
Closed -$1.36K – 2296
2024
Q3 		$1.36K Sell
26
-353
-93% -$16.9K ﹤0.01% 2302
2024
Q2 		$15.6K Buy
379
+359
+1,795% +$14.3K ﹤0.01% 2160
2024
Q1 		$867 Buy
+20
New +$875 ﹤0.01% 2243
2023
Q4 		– Sell
-2,260
Closed -$51.8K – 2663
2023
Q3 		$51.8K Buy
2,260
+1,620
+253% +$36.3K ﹤0.01% 2261
2023
Q2 		$10.6K Buy
+640
New +$11.6K ﹤0.01% 2536

Other funds holding RYTM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Allspring Global Investments's RYTM Position: Q4 2024 in Review

Allspring Global Investments sold out of Rhythm Pharmaceuticals (RYTM) in Q4 2024, closing a stake of 26 shares — an estimated $1.36K sold.

Allspring Global Investments first reported a position in RYTM in Q2 2023 and held it in 5 quarters. The position peaked at $51.8K in Q3 2023. 203 funds tracked by Wall St. Rank hold RYTM as of Q4 2024.

  • Allspring Global Investments reported no remaining Rhythm Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Allspring Global Investments sold 26 Rhythm Pharmaceuticals shares in Q4 2024, an estimated $1.36K.
  • Allspring Global Investments first reported a position in Rhythm Pharmaceuticals in Q2 2023 and held it in 5 quarters.
  • Allspring Global Investments's Rhythm Pharmaceuticals position peaked at $51.8K in Q3 2023.
  • 203 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q4 2024.

Based on Allspring Global Investments's 13F filing for Q4 2024, filed 29 Jan 2025.